Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

Inhaled Medications

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...

Chronic Obstructive Pulmonary Disease-V: Management

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Population Health Management in Chronic Obstructive Pulmonary Disease: An Official American Thoracic Society Workshop Report.

Annals of the American Thoracic Society·2026

Same author

Receipt of Weight Management Services Among Patients With OSA and Obesity.

CHEST pulmonary·2026

Same author

Receipt of glucagon-like peptide-1 receptor agonists among rural patients with obstructive sleep apnea and excess weight.

Annals of the American Thoracic Society·2026

Same author

Sunshine Act expansion and the prescription of generic medications by advanced practice providers.

Health affairs scholar·2026

Same author

Effect of a self-directed lifestyle-based weight management program among patients with comorbid COPD and sleep apnea: a secondary analysis of the INSIGHT COPD trial.

Annals of the American Thoracic Society·2025

Same author

Long-term outcomes associated with the super-exacerbator phenotype after a hospitalization for COPD.

American journal of respiratory and critical care medicine·2025

Search research articles

Related Experiment Video

Updated: Jun 24, 2026

Conducting Respiratory Oscillometry in an Outpatient Setting

Conducting Respiratory Oscillometry in an Outpatient Setting

Published on: April 8, 2022

Medication use patterns associated with spirometry in diagnosing COPD.

Min J Joo¹, Todd A Lee, David H Au

¹Center for Management of Complex Chronic Care (CMC3), Hines VA Hospital, Hines, Illinois, USA. joo@uic.edu

|April 9, 2009

Summary

This summary is machine-generated.

Spirometry use in newly diagnosed COPD patients was linked to increased respiratory medication use and additions. This suggests spirometry may guide more comprehensive COPD management strategies.

Related Experiment Videos

Last Updated: Jun 24, 2026

Conducting Respiratory Oscillometry in an Outpatient Setting

Conducting Respiratory Oscillometry in an Outpatient Setting

Published on: April 8, 2022

Area of Science:

Pulmonary Medicine
Health Services Research

Background:

Spirometry is crucial for diagnosing and staging Chronic Obstructive Pulmonary Disease (COPD) but is underutilized.
Inhaled therapies improve COPD outcomes but carry risks, potentially mitigated by spirometry-guided treatment.
Understanding the relationship between spirometry and medication use is key to optimizing COPD care.

Purpose of the Study:

To investigate the association between spirometry use and respiratory medication management in patients newly diagnosed with COPD.

Main Methods:

Retrospective, longitudinal study using Department of Veterans Affairs data.
Identified patients with new COPD diagnoses and analyzed spirometry use (2 years prior to 6 months after diagnosis).
Assessed respiratory medication dispensing within one year post-diagnosis, using logistic regression adjusted for propensity scores.

Main Results:

Out of 81,162 patients, 30.8% underwent spirometry.
Spirometry use was associated with higher likelihoods of receiving inhaled corticosteroids, long-acting beta-agonists, and ipratropium bromide.
Patients with spirometry were more likely to have respiratory medications added to their regimen.

Conclusions:

Spirometry use near the time of a new COPD diagnosis correlates with increased initiation and addition of respiratory medications.
These findings highlight spirometry's role in potentially driving more proactive and comprehensive medication management for COPD patients.